Public Reporting Opportunity Now Available for CathPCI Registry and ICD Registry Hospitals
All hospitals participating in the CathPCI Registry and/or ICD Registry now have the opportunity to review and voluntarily report their results on several registry-specific measures. Hospitals that choose to participate in this effort will have their rating posted on CardioSmart.org, ACC’s patient education and empowerment initiative.
The following National Quality Forum-endorsed measures are eligible for public reporting at this time:
- ICD Registry
- Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker (ACE/ARB) Therapy at Discharge for ICD Implant Patients With Left Ventricular Systolic Dysfunction (LVSD)
- Beta Blocker at Discharge for ICD Implant Patients With a Previous Myocardial Infarction
- Beta Blocker at Discharge for ICD Implant Patients With LVSD
- Composite: Discharge Medications (ACE/ARB and beta blockers) in Eligible ICD Implant Patients
- CathPCI Registry
- Proportion of Patients With Aspirin Prescribed at Discharge
- Proportion of Patients With a P2Y12 Inhibitor Prescribed at Discharge (Patients With Stents)
- Proportion of Patients With a Statin Prescribed at Discharge
- Composite: Discharge Medications (Aspirin, P2Y12 inhibitor, and Statin) in Eligible PCI Patients
In late October or early November, measure ratings for hospitals that have opted-in will be released to the public via CardioSmart’s Find Your Heart a Home tool, designed to connect cardiac patients and caregivers with the right hospital. This tool will give patients and caregivers access to demographics and publicly reported data, important information that can help them understand the quality of care being provided in their area and make informed choices.
Additionally, a Data Quality Checklist is now available to help NCDR hospitals ensure that all steps in their data management process produce complete, accurate, reliable and valid data. The checklist is accessible via the Quality Improvement for Institutions Clinical Toolkits page (select “Public Reporting Toolkit”). This tool is part of a new Public Reporting Toolkit designed to help NCDR hospitals improve on overall quality and performance for all registries, as well as publicly reported ICD Registry and CathPCI Registry metrics. Stay tuned for the release of CathPCI Registry and ICD Registry-specific data quality improvement tools.
The ACC encourages eligible hospitals to take advantage of this public reporting opportunity to demonstrate their commitment to transparency and quality improvement.
Contact your hospital’s Registry Site Manager to gain access to your institution's 2014 performance report. Learn more about this public reporting opportunity and how to enroll.
Keywords: Adrenergic beta-Antagonists, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Aspirin, Caregivers, Demography, Myocardial Infarction, Patient Discharge, Quality Improvement, Registries, Stents, Arrhythmias, Cardiac
< Back to Listings